General Archive
-
News releasesMRC Technology, UCB and the University of Leicester combine research excellence and expertise to evolve drug discovery
New research consortium aims to identify opportunities for drug discovery through the innovative use of antibodies in structure-based drug discovery…
-
News releases
New collaboration to explore novel treatments for respiratory diseases
A charity-industry collaboration has launched an initiative to find new epigenetic drug treatments to improve the lives of millions of…
-
News releases
MRC Technology monetises royalties on cancer drug Keytruda® (pembrolizumab) to expand medical research activities, with a fund managed by DRI Capital
MRC Technology has monetised a portion of its royalty interest in a leading cancer drug, pembrolizumab (marketed by Merck &…
-
News releases
MRC Technology and Keio University to collaborate on drug discovery
MRC Technology and Keio University School will collaborate to identify promising antibody and small molecule research and translate them into…
-
News releases
Patent protection for biotech/genetic engineering: report
Andrew Farquarson, Director, Technology Transfer, has been a member of the EU Commission’s Expert Group appointed in 2012 to advise on…
-
News releases
Enhancing patient benefit from research spending: MRC Technology and DEBRA Austria sign agreement
MRC Technology, a medical research charity, has signed an agreement to review DEBRA Austria’s research portfolio, aiming to identify promising…
-
News releases
Keytruda receives another breakthrough designation
Merck, known as MSD outside the United States and Canada, announced that the US Food and Drug Administration (FDA) has…
-
News releases
MRC Technology completes move to Stevenage open innovation campus
MRC Technology has completed the move of its Centre for Therapeutics Discovery to state-of-the-art laboratory facilities at the SBC campus.…
-
News releases
MRC Technology appoints two new members to board of trustees
MRC Technology, an independent life science medical research charity, has appointed Dr Les Hughes and Dr Mike Romanos to the…
-
News releases
MRC Technology and Institut Pasteur of Shanghai, Chinese Academy of Sciences collaborate on antibody drug development
MRC Technology and Institut Pasteur of Shanghai, Chinese Academy of Sciences (IPS-CAS) have signed a collaboration agreement to develop new…
-
News releases
MSD joins £4.5 million Dementia Consortium
Dementia Consortium welcomes MSD as a new partner in their global venture to accelerate drug discovery for neurodegenerative disease. MSD…
-
News releases
US team tackle immune system in £875,000 Dementia Consortium project
New dementia drug discovery efforts get underway this month at the University of South Florida, thanks to £875,000 funding from…